Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 2
1999 2
2000 1
2001 1
2002 3
2005 3
2006 7
2007 7
2008 6
2009 2
2010 1
2011 3
2012 2
2013 1
2014 3
2015 7
2016 4
2017 2
2018 3
2019 4
2020 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.
Isbell LK, Uibeleisen R, Friedl A, Burger E, Dopatka T, Scherer F, Orban A, Lauer E, Malenica N, Semenova I, Vreden A, Valk E, Wendler J, Neumaier S, Fricker H, El Rabih AAH, Gloggengießer C, Hilbig D, Bleul S, Weis J, Gmehlin D, Backenstrass M, Wirtz S, Ihorst G, Finke J, Illerhaus G, Schorb E. Isbell LK, et al. Among authors: backenstrass m. BMC Cancer. 2023 Aug 18;23(1):767. doi: 10.1186/s12885-023-11193-7. BMC Cancer. 2023. PMID: 37596517 Free PMC article. Clinical Trial.
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Schorb E, Isbell LK, Kerkhoff A, Mathas S, Braulke F, Egerer G, Röth A, Schliffke S, Borchmann P, Brunnberg U, Kroschinsky F, Möhle R, Rank A, Wellnitz D, Kasenda B, Pospiech L, Wendler J, Scherer F, Deckert M, Henkes E, von Gottberg P, Gmehlin D, Backenstraß M, Jensch A, Burger-Martin E, Grishina O, Fricker H, Malenica N, Orbán A, Duyster J, Ihorst G, Finke J, Illerhaus G. Schorb E, et al. Among authors: backenstrass m. Lancet Haematol. 2024 Mar;11(3):e196-e205. doi: 10.1016/S2352-3026(23)00371-X. Epub 2024 Jan 29. Lancet Haematol. 2024. PMID: 38301670 Clinical Trial.
Combining baseline characteristics to disentangle response differences to disorder-specific versus supportive psychotherapy in patients with persistent depressive disorder.
Serbanescu I, Walter H, Schnell K, Kessler H, Weber B, Drost S, Groß M, Neudeck P, Klein JP, Assmann N, Zobel I, Backenstrass M, Hautzinger M, Meister R, Härter M, Schramm E, Schoepf D. Serbanescu I, et al. Among authors: backenstrass m. Behav Res Ther. 2020 Jan;124:103512. doi: 10.1016/j.brat.2019.103512. Epub 2019 Nov 4. Behav Res Ther. 2020. PMID: 31734568 Clinical Trial.
[Prospects in psychotherapy research].
Mundt C, Backenstrass M. Mundt C, et al. Among authors: backenstrass m. Nervenarzt. 2001 Jan;72(1):11-9. doi: 10.1007/s001150050707. Nervenarzt. 2001. PMID: 11221551 Review. German.
62 results